Table of Contents PART 01: Executive summary PART 02: Scope of the report PART 03: Research methodology PART 04: Introduction • Market outline PART 05: Market landscape • Market overview • Market size and forecast • Five forces analysis PART 06: Market segmentation by technology • Market overview • Immunoassay testing • POCT • Molecular testing PART 07: Market segmentation by end-user • Market overview • Hospital and clinics • Diagnostic laboratories PART 08: Geographical segmentation • Sepsis diagnostics market in Americas • Sepsis diagnostics market in EMEA • Sepsis diagnostics market in APAC PART 09: Decision framework PART 10: Drivers and challenges • Market drivers • Market challenges PART 11: Market trends • Development of novel products • Increasing use of biomarkers for sepsis • Increasing online campaigns for sepsis awareness PART 12: Vendor landscape • Competitive landscape PART 13: Key vendors • bioMérieux • T2 Biosystems • Key companies to watch • Other prominent vendors • List of abbreviations PART 14: Appendix List of Exhibits Exhibit 01: Stages of sepsis Exhibit 02: Products offered for severity of sepsis Exhibit 03: Market overview: Global sepsis diagnostics market 2016-2021 Exhibit 04: Global sepsis diagnostics market 2016-2021 ($ millions) Exhibit 05: Reimbursement for sepsis in the US Exhibit 06: Five forces analysis Exhibit 07: Market overview of sepsis diagnostics by technology 2016 Exhibit 08: Global sepsis diagnostics market by immunoassay testing 2016-2021 ($ millions) Exhibit 09: Global sepsis diagnostics market by POCT 2016-2021 ($ millions) Exhibit 10: Global sepsis diagnostics market by molecular testing 2016-2021 ($ millions) Exhibit 11: Strategic analysis: Global sepsis diagnostics market by end-users 2016 Exhibit 12: Buying criteria for global sepsis diagnostics market by end user 2016 Exhibit 13: Global sepsis diagnostics market by geography in 2016 and 2021 ($ millions) Exhibit 14: Market overview: Sepsis diagnostics market in Americas 2016-2021 Exhibit 15: Sepsis diagnostics market in Americas 2016-2021 ($ millions) Exhibit 16: Market overview: Sepsis diagnostics market in EMEA 2016-2021 Exhibit 17: Sepsis diagnostics market in EMEA 2016-2021 ($ millions) Exhibit 18: Market overview: Sepsis diagnostics market in APAC 2016-2021 Exhibit 19: Sepsis diagnostics market in APAC 2016-2021 ($ millions) Exhibit 20: Market analysis: Sepsis-related to HAI Exhibit 21: Ongoing clinical trials by NHS in the UK Exhibit 22: Competitive structure analysis of global sepsis diagnostics market 2016 Exhibit 23: Market penetration of various global sepsis diagnostics market providers 2016 Exhibit 24: Strategic success factors of companies in global sepsis diagnostics market 2016 Exhibit 25: bioMérieux: Key highlights Exhibit 26: bioMérieux: Strength assessment Exhibit 27: bioMérieux: Strategy assessment Exhibit 28: bioMérieux: Opportunity assessment Exhibit 29: T2 Biosystems: Key highlights Exhibit 30: T2 Biosystems: Strength assessment Exhibit 31: T2 Biosystems: Strategy assessment Exhibit 32: T2 Biosystems: Opportunity assessment Exhibit 33: Abbott: Company assessment Exhibit 34: Nanosphere: Company assessment

bioMérieux, T2 Biosystems, Alere, Abionic, AdvanDx, Aethlon Medical, AusDiagnostics, Beckman Coulter, Beckton Dickinson, Momentum Bioscience, Bio-Rad Laboratories, Bruker, Cepheid, Curetis, CytoSorbents, Fast Track Diagnostics, F. Hoffmann-La Roche, Fujirebio Europe, Hansa Medical, Hain Lifescience, Immunexpress, Inflammatix, Merck, miacom diagnostics, Mitsubishi Chemical Europe, Nanōmix, QIAGEN, Radiometer, Response Biomedical, Sepset Biosciences, Siemens Healthineers, TCS Biosciences, and Thermo Fisher Scientific.